Re: Mathieu Rouanne, Dean F. Bajorin, Raquibul Hannan, et al. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder. Eur Urol Oncol 2020;3:728-38.

Authors	Francesco Montorsi, Alberto Martini
Journal	European urology oncology (Eur Urol Oncol) Vol. 4 Issue 2 Pg. 336 (04 2021) ISSN: 2588-9311 [Electronic] Netherlands
PMID	33541839 (Publication Type: Letter, Comment)
Topics	Carcinoma, Transitional Cell (therapy) Humans Immunotherapy Neoadjuvant Therapy Urinary Bladder Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!